Decoding the Adaptability–Rigidity Puzzle: Evidence from Pharmaceutical Incumbents’ Pursuit of Gene Therapy and Monoclonal Antibodies
The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
The emergence of radical technologies presents a significant challenge to incumbent firms. We study firms’ management of radical technological change by separating their actions into upstream research (the “R” of R&D) and downstream development (the “D” of R&D). We introduce two contingencies to explain when incumbents’ research investments in radical technologies translate into product development and when these upstream investments may get voided by organizational inertia downstream. First, radical technologies can differ in how they conform to incumbents’ existing business models, impacting the extent to which the movement of research outputs toward development will be subject to inertial pressures. Second, incumbents can invest in a radical technology through a variety of modes (internal research, external research contracts, alliances, acquisitions). These modes represent unique combinations of who does research and who is involved in the decision for subsequent development, and, hence, differ in the extent to which they are shielded from inertial pressures. This difference helps explain why incumbents, despite responding to radical technologies, may still be unable to adapt, as well as what types of investments will be more effective in helping firms navigate technological change. Evidence from pharmaceutical incumbents’ pursuit of monoclonal antibodies and gene therapy offers strong support for our arguments.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Technological paradigms and technological trajectories
Dosi, G. (1982) · Research Policy · doi:10.1016/0048-7333(82)90016-6 · Cited by 6,685
Regression Analysis of Count Data
Cameron, A. C., & Trivedi, P. K. (2013) · doi:10.1017/cbo9781139013567 · Cited by 6,640
Core capabilities and core rigidities: A paradox in managing new product development
Leonard-Barton, D. (1992) · Strategic Management Journal · doi:10.1002/smj.4250131009 · Cited by 6,477
Mostly Harmless Econometrics: An Empiricist's Companion
Angrist, J. D., & Pischke, J.-S. (2008) · doi:10.2307/j.ctvcm4j72 · Cited by 5,051
The use of logit and probit models in strategic management research: Critical issues
Hoetker, G. (2007) · Strategic Management Journal · doi:10.1002/smj.582 · Cited by 1,519
Unbundling the structure of inertia: Resource versus routine rigidity
Gilbert, C. G. (2005) · Academy of Management Journal · doi:10.5465/amj.2005.18803920 · Cited by 1,375
Controlling for endogeneity with instrumental variables in strategic management research
Bascle, G. (2008) · Strategic Organization · doi:10.1177/1476127008094339 · Cited by 1,133
Incumbent's advantage through exploiting complementary assets via interfirm cooperation
Rothaermel, F. T. (2001) · Strategic Management Journal · doi:10.1002/smj.180 · Cited by 1,114 · cited 11×
“Incumbents have been shown to successfully adapt if they invest in new technologies and possess complementary assets that are necessary for the technology’s commercialization (e.g., Rothaermel, 2001; Tripsas, 1997).”
BackgroundMethodResultInfluentialFading Memories: A Process Theory of Strategic Business Exit in Dynamic Environments
Burgelman, R. A. (1994) · Administrative Science Quarterly · doi:10.2307/2393493 · Cited by 1,018 · cited 4×
“At the same time, the presence of alternative technological solutions to those within disruptive technological regimes may require firms to make trade-offs in their resource allocation, which may further diminish the prospects for initiating product development in such technologies (Burgelman, 1994).”
BackgroundInfluentialEggers, J. P., & Kaplan, S. (2009) · Organization Science · doi:10.1287/orsc.1080.0401 · Cited by 774 · cited 1×
“Recent studies, however, have consistently found incumbents to be more responsive to and to invest in the radical technology (e.g., Eggers & Kaplan, 2009; Rothaermel, 2001; Tripsas, 1997).”
Background
Cited by
Disruptive Innovation: An Intellectual History and Directions for Future Research
Christensen, C. M., McDonald, R., Altman, E. J., & Palmer, J. E. (2018) · Journal of Management Studies · doi:10.1111/joms.12349 · Cited by 789
“…and newspapers (Gilbert, 2005, 2006 ), cardiovascular surgery (Christensen et al., 2009), management consulting (Christensen et al., 2013), cameras (Christensen, 2006), pharmaceuticals (Kapoor and Klueter, 2015), digital video recorders (Ansari et al., 2016), and financial services (Das, 2017).”
InfluentialEggers, J. P., & Park, K. F. (2018) · Academy of Management Annals · doi:10.5465/annals.2016.0051 · Cited by 326
An Ecosystem‐Level Process Model of Business Model Disruption: The Disruptor's Gambit
Snihur, Y., Thomas, L. D. W., & Burgelman, R. A. (2018) · Journal of Management Studies · doi:10.1111/joms.12343 · Cited by 229
Lou, B., & Wu, L. (2021) · MIS Quarterly · doi:10.25300/misq/2021/16565 · Cited by 177
“investigational drug database from Clarivate Analytics (Hess and Rothaermel 2011; Kapoor and Klueter 2015; Krieger et al. 2018).”
Contextual factors of disruptive innovation: A systematic review and framework
Antonio, J. L., & Kanbach, D. K. (2023) · Technological Forecasting and Social Change · doi:10.1016/j.techfore.2022.122274 · Cited by 74
Metadata
- Authors
- Kapoor, R., & Klueter, T.
- Venue
- Academy of Management Journal
- Publisher
- Academy of Management
- Published
- 2015-08
- Volume
- 58
- Issue
- 4
- Pages
- 1180-1207
- ISSN
- 0001-4273 (ISSN-L)
- 1948-0989
- OpenAlex
- W2134543901
- Cited by
- 150
- References
- 10
- FWCI
- 13.40
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Decoding the Adaptability–Rigidity Puzzle: Evidence from Pharmaceutical Incumbents’ Pursuit of Gene Therapy and Monoclonal Antibodies. https://app.cochat.ai/papers/10.5465/amj.2013.0430
- The paper
- Kapoor, R., & Klueter, T. (2015). Decoding the Adaptability–Rigidity Puzzle: Evidence from Pharmaceutical Incumbents’ Pursuit of Gene Therapy and Monoclonal Antibodies. Academy of Management Journal. https://doi.org/10.5465/amj.2013.0430
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.